Abstract:Purpose Adverse drug events (ADEs) are a significant global public health concern, and they have resulted in high rates of hospital admissions, morbidity, and mortality. Prior to the use of machine learning and deep learning methods, ADEs may not become well recognized until long after a drug has been approved and is widely used, which poses a significant challenge for ensuring patient safety. Consequently, there is a need to develop computational approaches for earlier identification of ADEs not detected during pre-registration clinical trials. Methods This paper presents a state-of-the-art network-based approach that models patients as subgraphs composed of nodes of International Classification of Diseases (ICD) codes and directed edges illustrating disease progression. Four Graph Neural Network (GNN) variants were employed to make sub-graph level predictions that answer three Research Questions (RQ): 1) whether ADE(s) would occur given a patient's prior diagnoses history, 2) when an ADE would occur, and 3) which ADE would occur. The first and second RQs were addressed using a binary classification approach. The third RQ was addressed using a multi-label classification model. Results The proposed network-based approach demonstrated superior performance in predicting ADEs, with the GraphSage model exhibiting the highest accuracy for both RQ 1 (0.8863) and RQ 3 (0.9367), while the Graph Attention Networks (GAT) model was found to perform best for RQ 2 (0.8769). Furthermore, an analysis segmented by ADE classification revealed that while RQs 1 and 3 exhibited minimal variance across different ADE categories, a distinct advantage was observed for categories B, C, and E in the context of RQ 2 when applying this sub-graph method. Conclusion The network-based approach demonstrates the potential of GNNs in supporting the early detection and prevention of ADEs. Accurately predicting ADEs could enable healthcare professionals to make informed clinical decisions, take preventive measures and adjust medication regimens before serious adverse events occur. The proposed prediction method could also lead to optimized usage of healthcare resources by preventing hospital admissions and reducing the overall burden of adverse drug events on the healthcare systems.

A Graph Neural Network Approach for Product Relationship Prediction

Customer Engagement Prediction on Social Media: A Graph Neural Network Method

Research on Online Shopping Mall Product Classification Recommendation Based on Graph Neural Network

Causality-based CTR Prediction using Graph Neural Networks

Spatial Graph Neural Networks for Accurate Product Demand Prediction

Attributed Graph Neural Networks for Recommendation Systems on Large-Scale and Sparse Graph

Product modeling design method based on graph neural network and fuzzy inference theory

Learning Graph-based Embedding for Time-Aware Product Recommendation

Learning from Substitutable and Complementary Relations for Graph-based Sequential Product Recommendation

Proactive Return Prediction in Online Fashion Retail Using Heterogeneous Graph Neural Networks

Recommending Related Products Using Graph Neural Networks in Directed Graphs

Predicting Best-Selling New Products in a Major Promotion Campaign Through Graph Convolutional Networks

Self-explainable Graph Neural Network for Alzheimer's Disease And Related Dementias Risk Prediction

SGNNRec: A Scalable Double-Layer Attention-Based Graph Neural Network Recommendation Model

Data Considerations in Graph Representation Learning for Supply Chain Networks

Research on Machine Vision Effect Based on Graph Neural Network Decision

Enhanced Sub-graph Reconstruction Graph Neural Network for Recommendation

AliGraph: A Comprehensive Graph Neural Network Platform

Multi-Graph Convolutional Network for Relationship-Driven Stock Movement Prediction

Graph neural network-based subgraph analysis for predicting adverse drug events

Relation-Aware Graph Convolutional Networks for Agent-Initiated Social E-Commerce Recommendation